FDA strengthens warning on painkillers to curb abuse

The FDA will require new drug labels on long-acting, extended-release opioid painkillers. A boxed warning will highlight risks of use while pregnant, and new language will indicate the drugs should be reserved for treating only severe pain.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal (tiered subscription model), The · AAFP News Now

Published in Briefs: